257 related articles for article (PubMed ID: 21768515)
1. Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses.
Chang KC; Yew WW; Zhang Y
Antimicrob Agents Chemother; 2011 Oct; 55(10):4499-505. PubMed ID: 21768515
[TBL] [Abstract][Full Text] [Related]
2. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing with Mycobacterium tuberculosis.
Davies AP; Billington OJ; McHugh TD; Mitchison DA; Gillespie SH
J Clin Microbiol; 2000 Oct; 38(10):3686-8. PubMed ID: 11015384
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.
Jonmalung J; Prammananan T; Leechawengwongs M; Chaiprasert A
BMC Microbiol; 2010 Aug; 10():223. PubMed ID: 20727143
[TBL] [Abstract][Full Text] [Related]
4. Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of
Tam KK; Leung KS; Siu GK; Chang KC; Wong SS; Ho PL; Leung EK; Yam WC
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189582
[TBL] [Abstract][Full Text] [Related]
5. Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan.
Ando H; Mitarai S; Kondo Y; Suetake T; Sekiguchi JI; Kato S; Mori T; Kirikae T
Clin Microbiol Infect; 2010 Aug; 16(8):1164-8. PubMed ID: 19832709
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China.
Liu W; Chen J; Shen Y; Jin J; Wu J; Sun F; Wu Y; Xie L; Zhang Y; Zhang W
Clin Microbiol Infect; 2018 Sep; 24(9):1016.e1-1016.e5. PubMed ID: 29288021
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China.
Che Y; Bo D; Lin X; Chen T; He T; Lin Y
BMC Infect Dis; 2021 Jun; 21(1):605. PubMed ID: 34171989
[TBL] [Abstract][Full Text] [Related]
8. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT
BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001
[TBL] [Abstract][Full Text] [Related]
9. Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates.
Mphahlele M; Syre H; Valvatne H; Stavrum R; Mannsåker T; Muthivhi T; Weyer K; Fourie PB; Grewal HM
J Clin Microbiol; 2008 Oct; 46(10):3459-64. PubMed ID: 18753350
[TBL] [Abstract][Full Text] [Related]
10. Sputum PCR-single-strand conformational polymorphism test for same-day detection of pyrazinamide resistance in tuberculosis patients.
Sheen P; Méndez M; Gilman RH; Peña L; Caviedes L; Zimic MJ; Zhang Y; Moore DA; Evans CA
J Clin Microbiol; 2009 Sep; 47(9):2937-43. PubMed ID: 19535526
[TBL] [Abstract][Full Text] [Related]
11. Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm.
Simons SO; van der Laan T; Mulder A; van Ingen J; Rigouts L; Dekhuijzen PN; Boeree MJ; van Soolingen D
Clin Microbiol Infect; 2014 Oct; 20(10):1015-20. PubMed ID: 24890253
[TBL] [Abstract][Full Text] [Related]
12. Non-
Werngren J; Alm E; Mansjö M
J Clin Microbiol; 2017 Jun; 55(6):1920-1927. PubMed ID: 28404681
[TBL] [Abstract][Full Text] [Related]
13. Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960.
Maslov DA; Zaĭchikova MV; Chernousova LN; Shur KV; Bekker OB; Smirnova TG; Larionova EE; Andreevskaya SN; Zhang Y; Danilenko VN
Tuberculosis (Edinb); 2015 Sep; 95(5):608-12. PubMed ID: 26071666
[TBL] [Abstract][Full Text] [Related]
14. Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.
Velásquez GE; Calderon RI; Mitnick CD; Becerra MC; Huang CC; Zhang Z; Contreras CC; Yataco RM; Galea JT; Lecca LW; Murray MB
Antimicrob Agents Chemother; 2016 Nov; 60(11):6766-6773. PubMed ID: 27600032
[TBL] [Abstract][Full Text] [Related]
15. Correlation between pyrazinamide activity and pncA mutations in Mycobacterium tuberculosis isolates in Taiwan.
Huang TS; Lee SS; Tu HZ; Huang WK; Chen YS; Huang CK; Wann SR; Lin HH; Liu YC
Antimicrob Agents Chemother; 2003 Nov; 47(11):3672-3. PubMed ID: 14576145
[TBL] [Abstract][Full Text] [Related]
16. Improved Detection by Next-Generation Sequencing of Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates.
Maningi NE; Daum LT; Rodriguez JD; Mphahlele M; Peters RP; Fischer GW; Chambers JP; Fourie PB
J Clin Microbiol; 2015 Dec; 53(12):3779-83. PubMed ID: 26378284
[TBL] [Abstract][Full Text] [Related]
17. Mutations found in the pncA gene of Mycobacterium tuberculosis in clinical pyrazinamide-resistant isolates from a local region of China.
Zhang H; Bi LJ; Li CY; Sun ZG; Deng JY; Zhang XE
J Int Med Res; 2009; 37(5):1430-5. PubMed ID: 19930847
[TBL] [Abstract][Full Text] [Related]
18. [Studies on pncA gene mutations in M. tuberculosis isolates].
Wu X; Zhang J; Zhong M
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jan; 23(1):40-2. PubMed ID: 11778181
[TBL] [Abstract][Full Text] [Related]
19. [Detection of pncA mutation associated with pyrazinamide resistance in Mycobacterium tuberculosis by high-resolution melting cure analysis].
Hong CY; Wang F; Liu XL
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):198-201. PubMed ID: 23856143
[TBL] [Abstract][Full Text] [Related]
20. Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.
Mestdagh M; Fonteyne PA; Realini L; Rossau R; Jannes G; Mijs W; De Smet KA; Portaels F; Van den Eeckhout E
Antimicrob Agents Chemother; 1999 Sep; 43(9):2317-9. PubMed ID: 10471589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
